Showing results (1481-1490 of 6,749) with videos related to

Sort By:
Pageof 675
Bulletin Du Cancer|March 12, 2026
[Therapeutic de-escalation strategies in the use of anti-PD-1 and anti-PD-L1: Dose, frequency, and duration]Lila Philipps, Léo Mas, Thomas Samaille, et al.
FEBS Letters|February 20, 2008
Towards a molecular characterisation of pathological pathwaysRoland A Pache, Andreas Zanzoni, Jordi Naval, et al.
Deutsche Medizinische Wochenschrift (1946)|July 1, 1988
[Palliative laser therapy of advanced rectal carcinoma]J F Riemann, R de Mas, C Ginsbach, et al.
Plos One|March 28, 2008
Morphological evolution of spiders predicted by pendulum mechanicsJordi Moya-Laraño, Dejan Vinković, Eva De Mas, et al.
Clinical and Experimental Pharmacology & Physiology|March 19, 2008
Cyp2d6*3, *4, *5 and *6 polymorphisms and antipsychotic-induced extrapyramidal side-effects in patients receiving antipsychotic therapyAnna Crescenti, Sergi Mas, Patricia Gassó, et al.
Brain Research|July 21, 1987
Regional changes of brain Na+,K+-transporting adenosine triphosphatase related to ovarian functionA Rodriguez del Castillo, E Battaner, M Guerra, et al.
Critical Reviews in Oncology/Hematology|March 18, 2019
ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancerGina Rosas, Rossana Ruiz, Jhajaira M Araujo, et al.
Environmental Health Perspectives|February 1, 1995
Modeling of natural organic matter transport processes in groundwaterT C Yeh, J Mas-Pla, J F McCarthy, et al.
The Journal of Biological Chemistry|October 17, 1998
Molecular cloning of the oncofetal isoform of the human pancreatic bile salt-dependent lipaseE Pasqualini, N Caillol, L Panicot, et al.
Journal of Biotechnology|January 24, 2015
Antitumour efficacy of the selumetinib and trametinib MEK inhibitors in a combined human airway-tumour-stroma lung cancer modelChristophe Mas, Bernadett Boda, Mireille CaulFuty, et al.
Pageof 675